128 related articles for article (PubMed ID: 36756924)
1. Discovery of SI 1/20 and SI 1/22 as Mutual Prodrugs of 5-Fluorouracil and Imidazole-Based Heme Oxygenase 1 Inhibitor with Improved Cytotoxicity in DU145 Prostate Cancer Cells.
Salerno L; Sorrenti V; Pittalà V; Consoli V; Modica MN; Romeo G; Marrazzo A; Giuliano M; Zajdel P; Vanella L; Intagliata S
ChemMedChem; 2023 Apr; 18(8):e202300047. PubMed ID: 36756924
[TBL] [Abstract][Full Text] [Related]
2. Novel mutual prodrug of 5-fluorouracil and heme oxygenase-1 inhibitor (5-FU/HO-1 hybrid): design and preliminary
Salerno L; Vanella L; Sorrenti V; Consoli V; Ciaffaglione V; Fallica AN; Canale V; Zajdel P; Pignatello R; Intagliata S
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1378-1386. PubMed ID: 34167427
[TBL] [Abstract][Full Text] [Related]
3. Heme Oxygenase-1 Inhibition Sensitizes Human Prostate Cancer Cells towards Glucose Deprivation and Metformin-Mediated Cell Death.
Raffaele M; Pittalà V; Zingales V; Barbagallo I; Salerno L; Li Volti G; Romeo G; Carota G; Sorrenti V; Vanella L
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31137785
[TBL] [Abstract][Full Text] [Related]
4. Computational Designing and Prediction of ADMET Properties of Four Novel Imidazole-based Drug Candidates Inhibiting Heme Oxygenase-1 Causing Cancers.
Rahman M; Talukder A; Akter R
Mol Inform; 2021 Oct; 40(10):e2060033. PubMed ID: 34241977
[TBL] [Abstract][Full Text] [Related]
5. Novel imidazole derivatives as heme oxygenase-1 (HO-1) and heme oxygenase-2 (HO-2) inhibitors and their cytotoxic activity in human-derived cancer cell lines.
Salerno L; Pittalà V; Romeo G; Modica MN; Marrazzo A; Siracusa MA; Sorrenti V; Di Giacomo C; Vanella L; Parayath NN; Greish K
Eur J Med Chem; 2015; 96():162-72. PubMed ID: 25874340
[TBL] [Abstract][Full Text] [Related]
6. Development of 5-fluorouracil-dichloroacetate mutual prodrugs as anticancer agents.
Mironiuk-Puchalska E; Karatsai O; Żuchowska A; Wróblewski W; Borys F; Lehka L; Rędowicz MJ; Koszytkowska-Stawińska M
Bioorg Chem; 2023 Nov; 140():106784. PubMed ID: 37639758
[TBL] [Abstract][Full Text] [Related]
7. Discovery of BC-01, a novel mutual prodrug (hybrid drug) of ubenimex and fluorouracil as anticancer agent.
Jiang Y; Li X; Hou J; Huang Y; Jia Y; Zou M; Zhang J; Wang X; Xu W; Zhang Y
Eur J Med Chem; 2016 Oct; 121():649-657. PubMed ID: 27322756
[TBL] [Abstract][Full Text] [Related]
8. Development and characterization of a new inhibitor of heme oxygenase activity for cancer treatment.
Mucha O; Podkalicka P; Mikulski M; Barwacz S; Andrysiak K; Biela A; Mieczkowski M; Kachamakova-Trojanowska N; Ryszawy D; Białas A; Szelążek B; Grudnik P; Majewska E; Michalik K; Jakubiec K; Bień M; Witkowska N; Gluza K; Ekonomiuk D; Sitarz K; Gałęzowski M; Brzózka K; Dubin G; Józkowicz A; Dulak J; Łoboda A
Arch Biochem Biophys; 2019 Aug; 671():130-142. PubMed ID: 31276659
[TBL] [Abstract][Full Text] [Related]
9. Expression of heme oxygenase-1 (HSP32) in human prostate: normal, hyperplastic, and tumor tissue distribution.
Maines MD; Abrahamsson PA
Urology; 1996 May; 47(5):727-33. PubMed ID: 8650873
[TBL] [Abstract][Full Text] [Related]
10. Mutual Prodrugs of 5-Fluorouracil: From a Classic Chemotherapeutic Agent to Novel Potential Anticancer Drugs.
Ciaffaglione V; Modica MN; Pittalà V; Romeo G; Salerno L; Intagliata S
ChemMedChem; 2021 Dec; 16(23):3496-3512. PubMed ID: 34415107
[TBL] [Abstract][Full Text] [Related]
11. Combination of Heme Oxygenase-1 Inhibition and Sigma Receptor Modulation for Anticancer Activity.
Romeo G; Ciaffaglione V; Amata E; Dichiara M; Calabrese L; Vanella L; Sorrenti V; Grosso S; D'Amico AG; D'Agata V; Intagliata S; Salerno L
Molecules; 2021 Jun; 26(13):. PubMed ID: 34202711
[TBL] [Abstract][Full Text] [Related]
12. Prodrugs for nitroreductase-based cancer therapy-3: Antitumor activity of the novel dinitroaniline prodrugs/Ssap-NtrB enzyme suicide gene system: Synthesis, in vitro and in silico evaluation in prostate cancer.
Tokay E; Güngör T; Hacıoğlu N; Önder FC; Gülhan ÜG; Tok TT; Çelik A; Ay M; Köçkar F
Eur J Med Chem; 2020 Feb; 187():111937. PubMed ID: 31841727
[TBL] [Abstract][Full Text] [Related]
13. In vitro evaluation of novel N-acetylalaninate prodrugs that selectively induce apoptosis in prostate cancer cells.
McGoldrick CA; Jiang YL; Brannon M; Krishnan K; Stone WL
BMC Cancer; 2014 Sep; 14():675. PubMed ID: 25234292
[TBL] [Abstract][Full Text] [Related]
14. Induction of heme oxygenase-1 with hemin alleviates cisplatin-induced reproductive toxicity in male rats and enhances its cytotoxicity in prostate cancer cell line.
Heeba GH; Hamza AA; Hassanin SO
Toxicol Lett; 2016 Dec; 264():38-50. PubMed ID: 27815112
[TBL] [Abstract][Full Text] [Related]
15. Development of new promising antimetabolite, DFP-11207 with self-controlled toxicity in rodents.
Fukushima M; Iizuka K; Jin C; Zhang C; Hong M; Eshima K
Drug Des Devel Ther; 2017; 11():1693-1705. PubMed ID: 28652707
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic modification of Nrf2 in 5-fluorouracil-resistant colon cancer cells: involvement of TET-dependent DNA demethylation.
Kang KA; Piao MJ; Kim KC; Kang HK; Chang WY; Park IC; Keum YS; Surh YJ; Hyun JW
Cell Death Dis; 2014 Apr; 5(4):e1183. PubMed ID: 24743738
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of novel aryloxyalkyl derivatives of imidazole and 1,2,4-triazole as heme oxygenase-1 (HO-1) inhibitors and their antitumor properties.
Salerno L; Pittalà V; Romeo G; Modica MN; Siracusa MA; Di Giacomo C; Acquaviva R; Barbagallo I; Tibullo D; Sorrenti V
Bioorg Med Chem; 2013 Sep; 21(17):5145-53. PubMed ID: 23867390
[TBL] [Abstract][Full Text] [Related]
18. The significance of the expression of dihydropyrimidine dehydrogenase in prostate cancer.
Li Y; Mizutani Y; Shiraishi T; Nakamura T; Mikami K; Takaha N; Okihara K; Kawauchi A; Sakai T; Miki T
BJU Int; 2007 Mar; 99(3):663-8. PubMed ID: 17092280
[TBL] [Abstract][Full Text] [Related]
19. Nuclear translocation of haeme oxygenase-1 is associated to prostate cancer.
Sacca P; Meiss R; Casas G; Mazza O; Calvo JC; Navone N; Vazquez E
Br J Cancer; 2007 Dec; 97(12):1683-9. PubMed ID: 18026199
[TBL] [Abstract][Full Text] [Related]
20. Novel Structural Insight into Inhibitors of Heme Oxygenase-1 (HO-1) by New Imidazole-Based Compounds: Biochemical and In Vitro Anticancer Activity Evaluation.
Greish KF; Salerno L; Al Zahrani R; Amata E; Modica MN; Romeo G; Marrazzo A; Prezzavento O; Sorrenti V; Rescifina A; Floresta G; Intagliata S; Pittalà V
Molecules; 2018 May; 23(5):. PubMed ID: 29783634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
